ICICI Direct is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 2400 in its research report dated August 11, 2020.
Dolat Capital recommended accumulate rating on IPCA Laboratories with a target price of Rs 2106 in its research report dated August 12, 2020.
Overall, encouraged by a strong execution in Q1, IPCA labs has increased its revenue growth guidance for FY21 to 18-19 percent from 14-17 percent stated earlier.
There is much more to IPCA Labs than the HCQS opportunity. Its FY21 guidance reflects that.
Sharekhan is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 1750 in its research report dated June 17, 2020.
Prabhudas Lilladher is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 1839 in its research report dated June 17, 2020.
Dolat Capital recommended accumulate rating on IPCA Laboratories with a target price of Rs 1600 in its research report dated June 17, 2020.
ICICI Direct is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 1900 in its research report dated June 17, 2020.
Emkay Global Financial is bullish on IPCA Laboratories has recommended buy rating on the stock with a target price of Rs 1782 in its research report dated June 17, 2020.
Prabhudas Lilladher is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 1826 in its research report dated February 13, 2020.
Sharekhan is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 1590 in its research report dated February 13, 2020.
Sharekhan is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 1220 in its research report dated November 08, 2019.
Sharekhan is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 1135 in its research report dated August 14, 2019.
Prabhudas Lilladher recommended accumulate rating on Ipca Laboratories with a target price of Rs 1008 in its research report dated August 14, 2019.
ICICI Direct is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 1195 in its research report dated August 14, 2019.
Sharekhan is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 1135 in its research report dated April 30, 2019.
ICICI Direct is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 900 in its research report dated February 13, 2019.
Prabhudas Lilladher is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 829 in its research report dated November 15, 2018.
JM Financial is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 720 in its research report dated May 31, 2018.
Prabhudas Lilladher is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 837 in its research report dated May 31, 2018.
Prabhudas Lilladher is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 837 in its research report dated March 09, 2018.
ICICI Direct is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 715 in its research report dated February 09, 2018.
ICICI Direct recommended hold rating on Ipca Laboratories with a target price of Rs 525 in its research report dated May 31, 2017.
Axis Direct is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 580 in its research report dated February 16, 2017.